Replies to post #19683 on Synaptogenix Inc (SNPX)

[Investor2014]

At least you don’t seems to disagree that only a handful of diehard investors are talking about $SNPX.

Anyway, my reasoning is that given past history of the Briostatin trials that haven’t gone well there seems a good chance the next one won’t workout either and that’s despite the apparently ‘good’ Memantine explanation.